BIOLASE Awarded New Patent for Non-Contact Handpiece for Tissue Cutting

BIOLASE Awarded New Patent for Non-Contact Handpiece for Tissue Cutting 
IRVINE, CA -- (Marketwired) -- 04/16/13 --  BIOLASE, Inc. (NASDAQ:
BIOL), the world's leading dental laser manufacturer and distributor,
announced today that the U.S. Patent and Trademark Office has issued
BIOLASE a new patent for its non-contact handpiece for cutting both
hard and soft tissue with its revolutionary line of WaterLase(R)
all-tissue lasers. 
Patent 8,403,922 is titled "Non-Contact Handpiece for Laser Tissue
Cutting" and further expands BIOLASE's intellectual property position
in all-tissue laser dentistry. BIOLASE currently has a total of 182
issued and 162 pending U.S. and international patents. 
Federico Pignatelli, Chairman and Chief Executive Officer, commented,
"This new patent further expands and protects our industry-leading
WaterLase technology. Our ergonomic, non-contact laser handpiece is
the only one that is user-replaceable with multiple configurations of
focal spot sizes and optimal operational distances. This patent
should limit the ability of our competitors to challenge our
market-leading position in laser dentistry and all-tissue lasers. Our
non-contact handpieces should also drastically contribute to
safeguarding patients from the risks of cross contamination and move
dental practices closer to providing truly safe and infection-free
oral healthcare." 
"The optical components in our patented contra-angle, non-contact
handpiece are designed to provide a high-density, uniform laser beam
at a specific distance from the target tissue, which results in the
fastest possible cutting of both hard and soft tissue while
eliminating undesirable back reflections that can reduce
effectiveness," said Dmitri Boutoussov, Chief Technology Officer.
"The wide range of microlense tips in our non-contact handpiece gives
us the opportunity to expand on the remarkable clinical benefits of
BIOLASE's unique WaterLase patented technology in both dental and
other medical applications, such as orthopedics and ophthalmology." 
About BIOLASE, Inc.
 BIOLASE, Inc. is a biomedical company that
develops, manufactures and markets dental lasers and also distributes
and markets dental imaging equipment; products that are focused on
technologies that advance the practice of dentistry a
nd medicine. The
Company's laser products incorporate over 340 patented and
patent-pending technologies designed to provide biologically
clinically superior performance with less pain and faster recovery
times. Its imaging products provide cutting-edge technology at
competitive prices to deliver the best results for dentists and
patients. BIOLASE's principal products are dental laser systems that
perform a broad range of dental procedures, including cosmetic and
complex surgical applications, and a full line of dental imaging
equipment. BIOLASE has sold more than 22,000 lasers. Other products
under development address ophthalmology and other medical and
consumer markets. 
WaterLase(R) is a trademark of BIOLASE, Inc.  
For updates and information on WaterLase and laser dentistry, find
BIOLASE online at www.biolase.com, Facebook at
www.facebook.com/biolaseinc, Twitter at www.twitter.com/biolaseinc,
Pinterest at www.pinterest.com/biolase, LinkedIn at
www.linkedin.com/company/biolase, Instagram at
www.instagram.com/biolaseinc and YouTube at
www.youtube.com/biolasevideos.  
For further information, please contact: 
Michael Porter 
Porter, LeVay & Rose, Inc. 
212-564-4700